From: Second to fourth digit ratio (2D:4D) and concentrations of circulating sex hormones in adulthood
Right Hand | Left Hand | Δr-l | ||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2D:4D tertile | G | (95% CI) | P 2 trend | ρ 3 | P 4 | G | (95% CI) | P 2 trend | ρ 3 | P 4 | G | (95% CI) | P 2 trend | ρ 3 | P 4 | |
Testosterone (nmol/l) | I | 15.9 | (15.3 - 16.4) | 0.04 | -0.05 | 0.12 | 15.6 | (15.0 - 16.2) | 0.34 | -0.03 | 0.34 | 15.5 | (14.9 - 16.0) | 0.86 | -0.02 | 0.44 |
II | 15.3 | (14.8 - 15.9) | 15.3 | (14.7 - 15.8) | 15.3 | (14.7 - 15.8) | ||||||||||
III | 15.0 | (14.5 - 15.6) | 15.2 | (14.7 - 15.8) | 15.4 | (14.9 - 16.0) | ||||||||||
Free testosterone (pmol/l) | I | 242.1 | (232.1 - 252.0) | 0.07 | -0.04 | 0.19 | 237.4 | (227.7 - 247.2) | 0.50 | -0.02 | 0.51 | 236.6 | (226.8 - 246.4) | 0.81 | -0.03 | 0.42 |
II | 233.5 | (224.0 - 243.0) | 232.8 | (223.3 - 242.3) | 232.8 | (223.2 - 242.4) | ||||||||||
III | 229.1 | (219.7 - 238.6) | 232.7 | (223.1 - 242.3) | 234.9 | (225.2 - 244.6) | ||||||||||
Oestradiol (pmol/l) | I | 104.3 | (99.6 - 108.9) | 0.73 | 0.02 | 0.45 | 104.5 | (99.8 - 109.2) | 0.83 | 0.02 | 0.41 | 104.4 | (99.8 - 109.1) | 0.84 | -0.00 | 0.96 |
II | 105.6 | (100.9 - 110.3) | 105.3 | (100.6 - 109.9) | 105.7 | (101.0 - 110.5) | ||||||||||
III | 105.0 | (100.3 - 109.7) | 104.9 | (100.3 - 109.6) | 104.9 | (100.2 - 109.6) | ||||||||||
Free oestradiol (pmol/l) | I | 1.7 | (1.6 - 1.8) | 0.51 | 0.03 | 0.31 | 1.7 | (1.6 - 1.8) | 0.58 | 0.03 | 0.26 | 1.7 | (1.6 - 1.8) | 0.92 | -0.00 | 0.99 |
II | 1.7 | (1.7 - 1.8) | 1.7 | (1.6 - 1.8) | 1.7 | (1.7 - 1.8) | ||||||||||
III | 1.7 | (1.6 - 1.8) | 1.7 | (1.6 - 1.8) | 1.7 | (1.6 - 1.8) | ||||||||||
DHEAS (μmol/l) | I | 3.3 | (3.1 - 3.5) | 0.37 | -0.03 | 0.28 | 3.4 | (3.2 - 3.6) | 0.07 | -0.04 | 0.13 | 3.3 | (3.1 - 3.5) | 0.68 | 0.01 | 0.64 |
II | 3.4 | (3.2 - 3.6) | 3.2 | (3.0 - 3.4) | 3.2 | (3.0 - 3.4) | ||||||||||
III | 3.2 | (3.0 - 3.4) | 3.2 | (3.0 - 3.3) | 3.4 | (3.2 - 3.6) | ||||||||||
Androstenedione (nmol/l) | I | 4.2 | (3.9 - 4.4) | 0.30 | -0.05 | 0.12 | 4.2 | (4.0 - 4.4) | 0.31 | -0.04 | 0.26 | 4.2 | (4.0 - 4.4) | 0.96 | -0.02 | 0.52 |
II | 4.2 | (3.9 - 4.4) | 4.2 | (3.9 - 4.4) | 4.0 | (3.8 - 4.2) | ||||||||||
III | 4.0 | (3.8 - 4.2) | 4.0 | (3.8 - 4.2) | 4.2 | (4.0 - 4.4) | ||||||||||
Androstenediol glucoronide (ng/ml) | I | 13.9 | (13.0 - 14.8) | 0.11 | 0.05 | 0.11 | 14.0 | (13.2 - 14.9) | 0.32 | 0.03 | 0.32 | 14.2 | (13.3 - 15.1) | 0.49 | 0.02 | 0.57 |
II | 14.3 | (13.4 - 15.2) | 14.4 | (13.5 - 15.3) | 14.2 | (13.4 - 15.1) | ||||||||||
III | 14.8 | (13.9 - 15.7) | 14.6 | (13.7 - 15.5) | 14.6 | (13.7 - 15.5) | ||||||||||
SHHB (nmol/l) | I | 35.0 | (33.6 - 36.3) | 0.50 | -0.02 | 0.57 | 34.7 | (33.4 - 36.0) | 0.60 | -0.02 | 0.60 | 34.5 | (33.2 - 35.8) | 0.98 | -0.01 | 0.82 |
II | 33.9 | (32.6 - 35.2) | 34.0 | (32.8 - 35.3) | 34.0 | (32.7 - 35.3) | ||||||||||
III | 34.3 | (33.0 - 35.6) | 34.2 | (33.0 - 35.5) | 34.5 | (33.2 - 35.8) |